University of Leicester
Browse
Cost-effective sequence analysis of 113 genes....pdf (1.07 MB)

Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis

Download (1.07 MB)
journal contribution
posted on 2023-07-17, 14:29 authored by DM Panneman, RJ Hitti-Malin, LK Holtes, SE de Bruijn, J Reurink, EGM Boonen, MI Khan, M Ali, S Andréasson, E De Baere, S Banfi, M Bauwens, T Ben-Yosef, B Bocquet, M De Bruyne, BDL Cerda, F Coppieters, P Farinelli, T Guignard, CF Inglehearn, M Karali, U Kjellström, R Koenekoop, B de Koning, BP Leroy, M McKibbin, I Meunier, K Nikopoulos, KM Nishiguchi, JA Poulter, C Rivolta, E Rodríguez de la Rúa, P Saunders, F Simonelli, Y Tatour, F Testa, AAHJ Thiadens, C Toomes, AM Tracewska, HV Tran, H Ushida, V Vaclavik, VJM Verhoeven, M van de Vorst, C Gilissen, A Hoischen, FPM Cremers, S Roosing

Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are two groups of inherited retinal diseases (IRDs) where the rod photoreceptors degenerate followed by the cone photoreceptors of the retina. A genetic diagnosis for IRDs is challenging since >280 genes are associated with these conditions. While whole exome sequencing (WES) is commonly used by diagnostic facilities, the costs and required infrastructure prevent its global applicability. Previous studies have shown the cost-effectiveness of sequence analysis using single molecule Molecular Inversion Probes (smMIPs) in a cohort of patients diagnosed with Stargardt disease and other maculopathies. Methods: Here, we introduce a smMIPs panel that targets the exons and splice sites of all currently known genes associated with RP and LCA, the entire RPE65 gene, known causative deep-intronic variants leading to pseudo-exons, and part of the RP17 region associated with autosomal dominant RP, by using a total of 16,812 smMIPs. The RP-LCA smMIPs panel was used to screen 1,192 probands from an international cohort of predominantly RP and LCA cases. Results and discussion: After genetic analysis, a diagnostic yield of 56% was obtained which is on par with results from WES analysis. The effectiveness and the reduced costs compared to WES renders the RP-LCA smMIPs panel a competitive approach to provide IRD patients with a genetic diagnosis, especially in countries with restricted access to genetic testing.

Funding

Novartis

History

Author affiliation

Life Sciences: Genetics & Genome Biology

Version

  • VoR (Version of Record)

Published in

Frontiers in Cell and Developmental Biology

Volume

11

Pagination

1112270

Publisher

Frontiers Media

issn

2296-634X

eissn

2296-634X

Copyright date

2023

Available date

2023-07-17

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC